Wells Fargo & Company Pear Therapeutics, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.21 - $1.24 $2,125 - $12,551	10,122 Added 234.36%	14,441 $3,000
Q4 2022 Feb 13, 2023	BUY	$0.99 - $2.91 $2,038 - $5,991	2,059 Added 91.11%	4,319 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $2.27 $263 - $4,605	2,029 Added 878.35%	2,260 $5,000
Q2 2022 Aug 12, 2022	BUY	$1.54 - $6.48 $29 - $123	19 Added 8.96%	231 $0
Q1 2022 May 16, 2022	BUY	$3.67 - $7.63 $778 - $1,617	212 New	212 $1,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.